FINLAY-FR-2: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
←Membuat halaman berisi '{{Infobox drug | type = vaccine | target = COVID‑19 | vaccine_type = konjugat | routes_of_administration = suntikan intraotot|I...' |
Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5 |
||
| (5 revisi perantara oleh 4 pengguna tidak ditampilkan) | |||
Baris 1:
{{orphan|Oktober 2022}}
{{Infobox drug
| type = vaccine
Baris 6 ⟶ 7:
| synonyms = SOBERANA-02
}}
'''FINLAY-FR-2''' juga dikenal sebagai '''SOBERANA-02''', adalah sebuah kandidat [[vaksin COVID-19]] yang diproduksi oleh Institut Finlay, sebuah institut riset epidemiologi [[Kuba]]. Vaksin tersebut adalah [[vaksin konjugat]].<ref>{{Cite web|title=Phase-1 of clinical trials with Soberana 02 candidate begins in Cuba|access-date=2021-01-24|url=http://www.plenglish.com/index.php?o=rn&id=61424&SEO=vaccination-with-soberana-02-anti-covid-19-candidate-begins-in-cuba|language=en|archive-date=2021-01-01|archive-url=https://web.archive.org/web/20210101125052/https://www.plenglish.com/index.php?o=rn&id=61424&SEO=vaccination-with-soberana-02-anti-covid-19-candidate-begins-in-cuba|dead-url=no}}</ref> Kandidat tersebut menyusul kandidat vaksin sebelumnya yang disebut SOBERANA-01.<ref name="pmid33295312">{{cite journal | vauthors = Gorry C | title = SOBERANA, Cuba's COVID-19 Vaccine Candidates: Dagmar García-Rivera PhD | journal = MEDICC Review | volume = 22 | issue = 4 | pages = 10–15 | date = October 2020 | pmid = 33295312 | doi = | url = }}</ref>
==Referensi==
Baris 13 ⟶ 14:
{{COVID-19}}
[[
| |||